220 related articles for article (PubMed ID: 18689806)
1. Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist.
Castillo JG; Filsoufi F; Adams DH; Raikhelkar J; Zaku B; Fischer GW
Br J Anaesth; 2008 Nov; 101(5):618-26. PubMed ID: 18689806
[TBL] [Abstract][Full Text] [Related]
2. Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases.
Weingarten TN; Abel MD; Connolly HM; Schroeder DR; Schaff HV
Anesth Analg; 2007 Nov; 105(5):1192-9, table of contents. PubMed ID: 17959940
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative Management of Carcinoid Heart Disease for Valvular Surgery.
Dalal A; Stone M
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):1046-9. PubMed ID: 26776749
[No Abstract] [Full Text] [Related]
4. Current concepts in diagnosis and perioperative management of carcinoid heart disease.
Castillo JG; Silvay G; Solís J
Semin Cardiothorac Vasc Anesth; 2013 Sep; 17(3):212-23. PubMed ID: 23171718
[TBL] [Abstract][Full Text] [Related]
5. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease.
Bhattacharyya S; Raja SG; Toumpanakis C; Caplin ME; Dreyfus GD; Davar J
Eur J Cardiothorac Surg; 2011 Jul; 40(1):168-72. PubMed ID: 21156347
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of left-sided carcinoid heart disease.
Connolly HM; Schaff HV; Mullany CJ; Rubin J; Abel MD; Pellikka PA
Circulation; 2001 Sep; 104(12 Suppl 1):I36-40. PubMed ID: 11568027
[TBL] [Abstract][Full Text] [Related]
7. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
Massimino K; Harrskog O; Pommier S; Pommier R
J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
[TBL] [Abstract][Full Text] [Related]
8. Carcinoid heart disease: outcomes after surgical valve replacement.
Mokhles P; van Herwerden LA; de Jong PL; de Herder WW; Siregar S; Constantinescu AA; van Domburg RT; Roos-Hesselink JW
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1278-83. PubMed ID: 22219480
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid Heart Disease: Early Outcomes after Surgical Valve Replacement in Nine Patients.
Mujtaba SS; Clark S
Heart Surg Forum; 2018 Feb; 21(1):E040-E043. PubMed ID: 29485963
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of left-sided heart valve involvement before right-sided heart valve involvement in carcinoid heart disease.
Marupakula V; Vinales KL; Najib MQ; Lanza LA; Lee HR; Chaliki HP
Eur J Echocardiogr; 2011 Mar; 12(3):E18. PubMed ID: 21169284
[TBL] [Abstract][Full Text] [Related]
11. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.
Kinney MA; Warner ME; Nagorney DM; Rubin J; Schroeder DR; Maxson PM; Warner MA
Br J Anaesth; 2001 Sep; 87(3):447-52. PubMed ID: 11517130
[TBL] [Abstract][Full Text] [Related]
12. 4-Valve Heart Disease and Right Heart Failure.
Hollon M; Glas K; Sumler M
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):838-845. PubMed ID: 29395828
[TBL] [Abstract][Full Text] [Related]
13. Development of effective prophylaxis against intraoperative carcinoid crisis.
Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
[TBL] [Abstract][Full Text] [Related]
14. Quadruple Valve Replacement for Carcinoid Heart Disease.
Mujtaba SS; Clark S
Braz J Cardiovasc Surg; 2018; 33(4):398-403. PubMed ID: 30184038
[TBL] [Abstract][Full Text] [Related]
15. Inoperable Primary Ovarian Carcinoid Led to the Progression of Carcinoid Heart Disease From Right-Sided to Both-Sided Involvement.
Tadokoro T; Katsuki S; Ito K; Onitsuka K; Nakashima A; Sasaguri T; Miyata K; Yamamoto H; Mohri M
Circ Heart Fail; 2017 Jan; 10(1):. PubMed ID: 28069686
[No Abstract] [Full Text] [Related]
16. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
Condron ME; Pommier SJ; Pommier RF
Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
[TBL] [Abstract][Full Text] [Related]
17. Early and Late Outcomes of Surgical Treatment in Carcinoid Heart Disease.
Connolly HM; Schaff HV; Abel MD; Rubin J; Askew JW; Li Z; Inda JJ; Luis SA; Nishimura RA; Pellikka PA
J Am Coll Cardiol; 2015 Nov; 66(20):2189-2196. PubMed ID: 26564596
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoid heart disease].
el-Rassi I; Oroudji M; Tapia M; Depoix JP; Henri I; Cormier B; Vissuzaine C; Acar C
Arch Mal Coeur Vaiss; 1998 Jan; 91(1):79-82. PubMed ID: 9749268
[TBL] [Abstract][Full Text] [Related]
19. Hypotension following valve replacement surgery in carcinoid heart disease.
Hamid SK; Harris DN
Anaesthesia; 1992 Jun; 47(6):490-2. PubMed ID: 1616085
[TBL] [Abstract][Full Text] [Related]
20. Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence.
Davis LM; Nicou N; Martin W; Corcoran B; Mulholland N; Srirajaskanthan R; Ramage J; Wendler O; Vivian G
Nucl Med Commun; 2020 Jun; 41(6):575-581. PubMed ID: 32371675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
